E734-2507 Screening compound: 6-(2-{4-[(4-benzylpiperazin-1-yl)sulfonyl]phenyl}ethyl)-5H,6H,7H-pyrrolo[3,4-b]pyridine-5,7-dione

E734-2507 Screening compound: 6-(2-{4-[(4-benzylpiperazin-1-yl)sulfonyl]phenyl}ethyl)-5H,6H,7H-pyrrolo[3,4-b]pyridine-5,7-dione
E734-2507 Screening compound: 6-(2-{4-[(4-benzylpiperazin-1-yl)sulfonyl]phenyl}ethyl)-5H,6H,7H-pyrrolo[3,4-b]pyridine-5,7-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound E734-2507
6-(2-{4-[(4-benzylpiperazin-1-yl)sulfonyl]phenyl}ethyl)-5H,6H,7H-pyrrolo[3,4-b]pyridine-5,7-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E734-2507

Molecular Formula

C26H26N4O4S (C26 H26 N4 O4 S)

Compound Name

6-(2-{4-[(4-benzylpiperazin-1-yl)sulfonyl]phenyl}ethyl)-5H,6H,7H-pyrrolo[3,4-b]pyridine-5,7-dione

IUPAC name

6-(2-{4-[(4-benzylpiperazin-1-yl)sulfonyl]phenyl}ethyl)-5H6H7H-pyrrolo[34-b]pyridine-57-dione

SMILES

O=C(c1c2nccc1)N(CCc(cc1)ccc1S(N1CCN(Cc3ccccc3)CC1)(=O)=O)C2=O

InChI

InChI=1S/C26H26N4O4S/c31-25-23-7-4-13-27-24(23)26(32)30(25)14-12-20-8-10-22(11-9-20)35(33,34)29-17-15-28(16-18-29)19-21-5-2-1-3-6-21/h1-11,13H,12,14-19H2

InChI Key

BYDCWMPOHFSGGG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14913729

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

490.58

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.784

Distribution Coefficient, logD

1.777

Water Solubility, LogSw

-2.80

Polar Surface Area

74.630

Acid Dissociation Constant (pKa)

26.20

Base Dissociation Constant (pKb)

5.60

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.90

E734-2507 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Cysteine Proteases Inhibitors Library (7839 compounds)

Purinergic Library (3321 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Nervous system
  • Cardiovascular
  • Metabolic
Targets:
  • Proteases
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E734-2507 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E734-2507?
Check Price and Availability of E734-2507, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E734-2507 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E734-2507
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E734-2507
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E734-2507 available by request